I-SARS-CoV-2Antigen Rapid Test Kit (TRFIA) luvavanyo lwesangweji ye-immunofluorescent. Ukufunyanwa kwe-SARS-CoV-2 nucleocapsid protein antigen ingasetyenziselwa ukufumanisa isifo sentsholongwane ye-corona, kwaye iluncedo ekubhaqweni kwangoko kwenoveli. Usulelo lwentsholongwane ye-corona inyumoniya kwixesha elifihliweyo.Umcu wovavanyo uneenwebu eziqatywe ngaphambili ngempuku echasene ne-CoV N ye-protein ye-monoclonal antibodies kwimigca yovavanyo.Xa isampulu isetyenziswa kwisampulu yamaqula, iprotein ye-SARS-CoV N kunye neelebhile ze-antibody complexes ziyenziwa kwaye zinyuke ngomcu.I-microsphere fluorescent probe reagent ebhaliweyo isetyenziselwa ukwenza umgca obomvu obonakalayo onetotshi ye-UV ehambelanayo.Ubukho be-SARS-CoV-2 buya kuboniswa ngumgca wovavanyo obomvu obonakalayo (T) kwifestile yeziphumo.I-Membrane ifakwe ngaphambili kunye neChicken IgY kumgca wolawulo (C).Ulayini wolawulo (C) uvela kwifestile yesiphumo ngasinye xa isampulu ihambe ngomcu.Umgca woLawulo usetyenziswa njengolawulo lwenkqubo.Umgca wokulawula kufuneka uhlale ubonakala xa inkqubo yokuvavanya iqhutywe ngokufanelekileyo kwaye i-reagents isebenza njengoko ijoliswe kuyo.Uvavanyo lwe-antigen olukhawulezileyo sisixhobo sokuxilonga, kodwa asenzelwanga ukuqinisekisa usulelo olusebenzayo okanye ukuthintela usulelo phakathi kwabantu abangenazo iimpawu.Zenzelwe abantu abaneempawu ze-COVID-19, abantu abasondelelene nomntu oqinisekisiweyo we-COVID, kunye nokulandelela abantu abayinxalenye yoqhambuko.